Life Sciences Ontario’s Post

𝐒𝐩𝐢𝐧𝐚𝐥 𝐂𝐨𝐫𝐝 𝐈𝐧𝐣𝐮𝐫𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦: Inteligex CEO Paul Bradshaw on stem cells that are designed to account for regional identity differences within the spinal cord, and also engineering in a proliferation factor. He explains how Inteligex's "ReStaRT Cells" are designed with a regional identity, and the rationale for engineering them to express the ChABC and GDNF genes to boost the odds of survival and proliferation. Full video: https://lnkd.in/gvuKf98G BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent

When we talk about Cytogenetics and microarrays, the TAT is crucial, but not the only criterion to consider... reduction of DNA input, additional reference models, update of the chip content... Go faster, but also go further with Accel!

2032 Market Potential in Cell Line Authentication and Characterization Tests | Unlocking Strategies https://lnkd.in/eZiQxueu #marketanalysis #marketresearch #marketresearchreports #businessintelligence

Researchers Use DNA Nanoballs, Biosensors to Create Low-Cost Diagnostics. The creation of DNA nanoballs allows for the use of more simplified detection techniques, which potentially reduces the cost of testing. http://ow.ly/2pcJ104UgLM

New DNA nanobots can replicate themselves using UV light https://lnkd.in/drj7vSuq

Our Venture Partner Ilan Zipkin says it best -"The intersection of biological science and other tech affects a range of commercialization... convergent technology is going to be really necessary in the spinal cord field." Watch the full BiotechTV interview with Brian Orelli, PhD to learn how Breakout Ventures envisions the impact of augmenting cell therapies with the capabilities of other technologies. https://lnkd.in/gTmuxgU4

Discover how the choice of cell lines impacts biomaterial suitability and why evaluating temporal changes is key to accurate testing. https://bit.ly/43SamYs

T cell scientists, how do YOU measure the performance of your cell culture? Download a whitepaper detailing how a xeno-free serum replacement supports growth, expansion, viability, and increases transduction efficiency! https://hubs.ly/Q0250DPc0 #tcells #cellculture #celltherapy #cartcelltherapy #cellandgenetherapy

We are now facing complex biosecurity challenges and unforeseen concerns as DNA synthesis technology rapidly evolves. It’s reassuring to see that DNA screening technology is also advancing. SecureDNA offers a free, effective, cryptographically secure, and developer-friendly screening solution. DNA synthesis providers should definitely check this out! #DNASynthesis #SyntheticBiology #Biotechnology